Inhibitory effect of 17AAG on proliferation and invasion of hepatocellular carcinoma cells

Yue-hong CUI,Wei-zhong WU,Tian-shu LIU,Qian XIE,Kang-da LIU

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2011.10.004

2011-01-01

Abstract:Objective To observe whether 17AAG can inhibit the proliferation,invasion and metastatic ability of hepatocellular carcinoma (HCC) cells.Methods The changes of proliferative and invasive abilities and apoptosis of HCC cells treated with 1 μmol/L 17AAG were tested.The change of HSP90 expression in HCC cells treated with 0.1 and 1.0 μmol/L 17AAG was detected by using Western blotting.Results There was no growth inhibition in HL7702 hepatocytes.17AAG could inhibit the growth of HepG2 cells [IC50 of 24,48 and72 h:(14182.94 ±6369.90),(1.56±0.19) and (0.02±0.00)μmol/L] and MHCC-97H cells [ IC50 of 24,48 and 72 h:(5660.49 ± 3029.33 ),(3.30 ± 0.31 ) and ( 1.55 ±0.12) μmol/L],and decrease the ability of scattering and invasion.17AAG also affected the cell cycle and induced apoptosis of HepG2 and MHCC-97H cells.17AAG inhibited the growth of transplanted tumors in nude mice and the metastasis of the lung and liver.The expression of HSP90 was elevated by 17AAG.Conclusion 17AAG inhibited the proliferation and metastatic ability of HepG2 and MHCC-97H cells,and induced apoptosis.However,there were no growth inhibition and apoptosis induction in HL7702 hepatocytes.